Press Release

When Funding Whiplash Becomes the Risk: What the SAMHSA Grant Reversal Signals for Behavioral Health
January 27, 2026
In the span of 24 hours, the substance use disorder (SUD) field experienced a jolt that few leaders will soon…
Indiana Treatment Centers to Open New Treatment Center in Mishawaka, Expanding Access to Substance Use Disorder Treatment
January 25, 2026
Mishawaka, IN – Indiana Treatment Centers will soon open a new treatment center inMishawaka, expanding access to comprehensive substance use…
Ascension Recovery Services and Indiana Treatment Centers to Open New Treatment Center in Mishawaka, Expanding Access to Substance Use Disorder Treatment
January 15, 2026
Orlando, FL – January 15, 2026 – Ascension Recovery Services today announced that, through a partnership with Indiana Treatment Centers, a new…
Ascension Recovery Services Announces Major 2025 Milestones
December 16, 2025
Orlando, FL — December 4, 2025 — Ascension Recovery Services (Ascension RS), a national leader in behavioral health consulting, management, and program…
Ascension Recovery Services VP Biz Dev, VP Quality/Compliance & VP Operations
December 15, 2025
"These appointments reflect Ascension’s focus on expanding access to recovery services while holding the highest standards for quality, accountability, and…
Volunteers, Nurses Needed to Care for Boston’s Homeless Who Have COVID-19
November 27, 2025
Boston and Beyond News Volunteers, nurses needed to care for homeless with COVID-19 Boston needs both medical and nonmedical volunteers…
Sobering center opens in Morgantown
November 27, 2025
MORGANTOWN — Hope Hill Sobering Center, the newest addition to Hazel’s House of Hope, held a ribbon cutting and open…
Subscribe to email updates
Posts
- Frequently Asked Questions about Substance Use Disorder Recovery
- Alcohol Addiction Treatment: Alcoholism Signs
- Navigating the Shifting SUD Landscape: How to Stay Relevant Part 1
- Reintegrate Appalachia Awarded Grant From Appalachian Regional Commission (ARC) Power Initiative
- Addressing the Xylazine Crisis: ARS at the Forefront
